- Report
- November 2022
- 180 Pages
Global
From €5258EUR$5,950USD£4,632GBP
From €5258EUR$5,950USD£4,632GBP
- Report
- October 2020
- 220 Pages
North America
From €5258EUR$5,950USD£4,632GBP
- Report
- November 2024
Global
From €4374EUR$4,950USD£3,854GBP
- Report
- June 2024
Global
From €4374EUR$4,950USD£3,854GBP
- Report
- April 2024
- 62 Pages
Global
From €4374EUR$4,950USD£3,854GBP
- Report
- December 2023
- 67 Pages
Global
From €4374EUR$4,950USD£3,854GBP
- Report
- June 2023
- 70 Pages
Global
From €4374EUR$4,950USD£3,854GBP
- Report
- January 2023
- 73 Pages
Global
From €4374EUR$4,950USD£3,854GBP
- Report
- October 2022
- 70 Pages
Global
From €4374EUR$4,950USD£3,854GBP
- Report
- July 2025
- 200 Pages
Japan
From €2200EUR$2,490USD£1,939GBP
- Report
- October 2024
- 200 Pages
Europe
From €2200EUR$2,490USD£1,939GBP
- Report
- September 2023
- 190 Pages
Global
From €2200EUR$2,490USD£1,939GBP
- Report
- November 2024
- 206 Pages
Global
From €2209EUR$2,500USD£1,946GBP
- Report
- August 2024
- 185 Pages
Global
From €2209EUR$2,500USD£1,946GBP
- Report
- December 2024
- 159 Pages
Asia Pacific
From €2209EUR$2,500USD£1,946GBP
- Report
- November 2024
- 164 Pages
Global
From €2209EUR$2,500USD£1,946GBP
- Report
- November 2024
- 165 Pages
Global
From €2209EUR$2,500USD£1,946GBP
- Report
- August 2024
- 174 Pages
Global
From €2209EUR$2,500USD£1,946GBP
- Report
- August 2024
- 169 Pages
Global
From €2209EUR$2,500USD£1,946GBP

The Next Generation Sequencing (NGS) market is a subset of the biotechnology industry that focuses on the development and application of high-throughput sequencing technologies. NGS technologies enable the rapid and cost-effective sequencing of large amounts of DNA or RNA, allowing for the analysis of genetic variation and gene expression. This technology has been used to identify and characterize genetic mutations, to study gene expression, and to develop new diagnostics and therapeutics. NGS has also been used to study the evolution of viruses and bacteria, and to identify new species.
The NGS market is highly competitive, with a number of companies offering a range of sequencing technologies and services. Some of the major players in the market include Illumina, Thermo Fisher Scientific, BGI, Pacific Biosciences, Oxford Nanopore Technologies, and 10x Genomics. Show Less Read more